Patent opinions from the Eastern District of Texas and the U.S. Court of Appeals for the Federal Circuit

Weekly Digest
Fed. Cir.

Reckitt Benckiser LLC v. aurobindo Pharma Ltd., No. 17-1895 (Fed. Cir. Sept. 10, 2018)

Affirmed
Court
U.S. Court of Appeals for the Federal Circuit
Case No.
No. 17-1895
Also Docketed
No. 18-1131 (consolidated; same document)
Decided
September 10, 2018
Judge
Per curiam (Rule 36)
Document
Rule 36 Judgment
Length
2 pages

NOTE: This disposition is nonprecedential. United States Court of Appeals

for the Federal Circuit

RECKITT BENCKISER LLC,

Plaintiff-Appellant

v.

AUROBINDO PHARMA LTD., AUROBINDO

PHARMA USA INC.,

Defendants-Cross-Appellants

2017-1895, 2018-1131

Appeals from the United States District Court for the District of Delaware in No. 1:14-cv-01203-LPS, Chief Judge Leonard P. Stark.

JUDGMENT

DOUGLAS J. NASH, Barclay Damon, LLP, Syracuse, NY, argued for plaintiff-appellant. Also represented by LAURA VOGEL, Boston, MA; BELLA SATRA, Albany, NY. TIMOTHY KRATZ, Kratz & Barry LLP, Atlanta, GA, argued for defendants-cross-appellants. Also represented by GEORGE BARRY, III.

2THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED:

Circuit Judges).

AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT

September 10, 2018 /s/ Peter R. Marksteiner Date Peter R. Marksteiner Clerk of Court

Text extracted from the official PDF and reflowed for reading. It is not a certified transcript — the PDF linked above is the authoritative document.

Analysis is coming soon.

A plain-English account of the issues, facts and holding, written by Patent Case Watch. The opinion itself — its full text, its PDF and everything else on this page — stays free to read for everyone, always.

Cite this opinion

Reckitt Benckiser LLC v. aurobindo Pharma Ltd., No. 17-1895 (Fed. Cir. Sept. 10, 2018).

govinfo ID
USCOURTS-ca13-17-01895-0
Permalink
https://patentcasewatch.com/opinions/USCOURTS-ca13-17-01895-0

No reporter citation is shown because the official source does not supply one; none is inferred here. Check the opinion and a citator before relying on this form.